ANVISA Inspection (Agenica National De Vigilancia Sanitaria) has been received from Brazil Health Regulatory Agency at Wanbury Limited's manufacturing facility located at Tanuku, Andhra Pradesh.

Wanbury's Tanuku plant at Andhra Pradesh successfully completed ANVISA inspection (Brazil Health Regulatory Agency) starting from 16.12.2024 to 19.12.2024 (4 days) for its API manufacturing facility. Inspection completed with zero observations which means no observation during the inspection process for 5 APIs confirming strict adherence of cGMP practices at its state-of-the art API manufacturing facility.

The company will receive GMP compliance certificate which will further help to accelerate the business growth across the globe since ANVISA is part of PIC (Pharmaceutical Inspection Convention).

This is the second international FDA inspection with zero observations this year after USFDA inspection completed in June 2024 at Patalganga plant also with zero observations.